Voluntary participation and comprehension of informed consent in a genetic epidemiological study of breast cancer in Nigeria
- PMID: 24885380
- PMCID: PMC4032563
- DOI: 10.1186/1472-6939-15-38
Voluntary participation and comprehension of informed consent in a genetic epidemiological study of breast cancer in Nigeria
Abstract
Background: Studies on informed consent to medical research conducted in low or middle-income settings have increased, including empirical investigations of consent to genetic research. We investigated voluntary participation and comprehension of informed consent among women involved in a genetic epidemiological study on breast cancer in an urban setting of Nigeria comparing women in the case and control groups.
Methods: Surveys were administered in face-to-face interviews with 215 participants following their enrollment in the genetic study (106 patients, 109 controls). Audio-taped in-depth interviews were conducted with a sub-sample of 17 (8%) women who completed the survey.
Results: The majority of all participants reported being told that participation in the genetic study was voluntary (97%), that they did not feel pressured to participate in the study (99%), and that they could withdraw from the study (81%). The majority of the breast cancer patients (83%) compared to 58% of women in the control group reported that the study purpose was to learn about the genetic inheritance of breast cancer (OR 3.44; 95% CI =1.66, 7.14, p value = 0.001). Most participants reported being told about study procedures (95%) and study benefits (98%). Sixty-eight percent of the patients, compared to 47% of the control group reported being told about study risks (p-value <0.001). Of the 165 married women, 19% reported asking permission from their husbands to enroll in the breast cancer study; no one sought permission from local elders. In-depth interviews highlight the use of persuasion and negotiation between a wife and her husband regarding study participation.
Conclusions: The global expansion of genetic and genomic research highlights our need to understand informed consent practices for studies in ethnically diverse cultural environments such as Africa. Quantitative and qualitative empirical investigations of the informed consent process for genetic and genomic research will further our knowledge of complex issues associated with communication of information, comprehension, decisional authority and voluntary participation. In the future, the development and testing of innovative strategies to promote voluntary participation and comprehension of the goals of genomic research will contribute to our understanding of strategies that enhance the consent process.
Similar articles
-
Voluntary participation and informed consent to international genetic research.Am J Public Health. 2006 Nov;96(11):1989-95. doi: 10.2105/AJPH.2005.076232. Epub 2006 Oct 3. Am J Public Health. 2006. PMID: 17018820 Free PMC article.
-
Understanding and retention of the informed consent process among parents in rural northern Ghana.BMC Med Ethics. 2008 Jun 19;9:12. doi: 10.1186/1472-6939-9-12. BMC Med Ethics. 2008. PMID: 18565230 Free PMC article.
-
"I passed the test!" Evidence of diagnostic misconception in the recruitment of population controls for an H3Africa genomic study in Cape Town, South Africa.BMC Med Ethics. 2017 Feb 15;18(1):12. doi: 10.1186/s12910-017-0175-z. BMC Med Ethics. 2017. PMID: 28202021 Free PMC article.
-
The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 7: Informed consent and xenotransplantation clinical trials.Xenotransplantation. 2009 Jul-Aug;16(4):255-62. doi: 10.1111/j.1399-3089.2009.00546.x. Xenotransplantation. 2009. PMID: 19799766
-
Improvement of informed consent and the quality of consent documents.Lancet Oncol. 2008 May;9(5):485-93. doi: 10.1016/S1470-2045(08)70128-1. Lancet Oncol. 2008. PMID: 18452859 Review.
Cited by
-
Rapid Ethical Assessment on Informed Consent Content and Procedure in Hintalo-Wajirat, Northern Ethiopia: A Qualitative Study.PLoS One. 2016 Jun 3;11(6):e0157056. doi: 10.1371/journal.pone.0157056. eCollection 2016. PLoS One. 2016. PMID: 27258537 Free PMC article.
-
A perpetual source of DNA or something really different: ethical issues in the creation of cell lines for African genomics research.BMC Med Ethics. 2014 Aug 7;15:60. doi: 10.1186/1472-6939-15-60. BMC Med Ethics. 2014. PMID: 25104115 Free PMC article.
-
Informed consent in genetic and genomic studies in Sub-Saharan Africa: a systematic review of bioethical issues.BMC Med Ethics. 2025 Jul 19;26(1):99. doi: 10.1186/s12910-025-01170-z. BMC Med Ethics. 2025. PMID: 40682008 Free PMC article.
-
Understandings of genomic research in developing countries: a qualitative study of the views of MalariaGEN participants in Mali.BMC Med Ethics. 2015 Jun 16;16:42. doi: 10.1186/s12910-015-0035-7. BMC Med Ethics. 2015. PMID: 26077875 Free PMC article.
-
Stroke genomics in people of African ancestry: charting new paths.Cardiovasc J Afr. 2015 Mar-Apr;26(2 Suppl 1):S39-49. doi: 10.5830/CVJA-2015-039. Cardiovasc J Afr. 2015. PMID: 25962947 Free PMC article. Review.
References
-
- Chokshi DA, Kwiatkowski DP. Ethical challenges of genomic epidemiology in developing countries. Genomics Soc Policy. 2005;1:1–15. doi: 10.1186/1746-5354-1-1-1. - DOI
-
- Molyneux CS, Wassenaar DR, Peshu N, Marsh K. ‘Even if they ask you to stand by a tree all day, you will have to do it (laughter…!:) Community voices on the notion and practice of informed consent for biomedical research in developing countries. Soc Sci Med. 2005;61:443–454. doi: 10.1016/j.socscimed.2004.12.003. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical